Fortuna Fix

About:

Fortuna Fix is a clinical-stage biotech company .

Top Investors: Amgen Ventures, Salamander Invest AS

Description:

Fortuna Fix is a private, clinical-stage Regenerative Medicine company.the treatment of neurodegenerative diseases and neurotrauma. The company is focused on its lead programs in Spinal Cord Injury and Parkinson's disease with further development efforts in Stroke, Traumatic Brain Injury, Hearing Loss and ALS.

Total Funding Amount:

$25M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2015-01-01

Founders:

Jan-Eric Ahlfors, Vikram Lamba

Number of Employees:

11-50

Last Funding Date:

2017-11-08

IPO Status:

Private

Industries: